Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection)

This study has been completed.
Sponsor:
Collaborators:
International Rett Syndrome Foundation
Autism Speaks
Information provided by (Responsible Party):
Walter Kaufmann, Children's Hospital, Boston
ClinicalTrials.gov Identifier:
NCT01253317
First received: December 2, 2010
Last updated: January 24, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2013
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)